Publications by authors named "Lane Senne"

Claim this Profile
P
Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma.
Vivek Subbiah, Sant P Chawla, Anthony P Conley, Breelyn A Wilky, Anthony Tolcher, Lane Senne

Clin Cancer Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CTGF Oligonucleotide Reduces Severity of Postsurgical Hypertrophic Scars in a Randomized, Double-Blind, Within-Subject, Placebo-Controlled Study.
Jeff Jensen, Gary Gentzkow, Gabe Berman, Lane Senne, Mark Jewell

Plast Reconstr Surg· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis